Ageing: Repair and Transcription Keep Us from Premature Ageing  by Lehmann, Alan
Ageing: Repair and Transcription Keep
Us from Premature Ageing
Dispatch
Alan Lehmann
Trichothiodystrophy (TTD) is a complex disorder
caused by mutations in the XPD gene which affect
both DNA repair and transcription. A mouse with a
TTD mutation has now been found to display remark-
able signs of premature ageing.
DNA repair processes provide a major protection
mechanism against carcinogenesis, and about 15
genetic disorders are known to be associated with
defects in DNA repair [1]. Many of these disorders
involve predisposition to cancer, but they also have a
wide variety of other clinical features. This is because,
in many cases, the defective gene products have
other roles apart from their involvement in DNA repair
[2]. The xeroderma pigmentosum group D (XPD) gene
is particularly fascinating in this respect, because XPD
mutations can result in several different clinical phe-
notypes [3]. XPD is one of eight genes in which muta-
tions can cause the sun-sensitive cancer-prone skin
disorder xeroderma pigmentosum (XP). Other muta-
tions in XPD, however, can cause trichothiodystrophy
(TTD), a completely different multi-system disorder
characterised by brittle hair, ichthyotic skin, mental
and physical retardation, but no predisposition to
cancer [4]. In yet further rare instances, XPD mutations
lead to Cockayne syndrome (CS) or the combined fea-
tures of XP with CS, or XP with TTD. 
A mouse model for TTD was generated a few years
ago [5] and was shown to exhibit most of the features
of the TTD patients, namely brittle hair, which period-
ically falls out and re-grows, ichthyotic skin, reduced
stature and a failure to thrive. De Boer et al. [6] have
now reported a novel feature of the TTD mice that they
generated, namely premature ageing. At 15 months,
the mice look strikingly old with large patches of grey
hair and skin, they become cachectic (loss of body fat)
and develop kyphosis (curvature of the spine) and
osteoporosis (Figure 1). The progressive cachexia
leads to early death. Premature ageing has not been
reported for TTD patients, although in most cases they
die very young.
An important clue to unravelling the complexity of
genotype–phenotype relationships in the XPD gene
came from the discovery that the XPD protein is a
subunit of the basal transcription factor TFIIH, which
is required both for initiation of transcription by RNA
polymerase II and for nucleotide excision repair of
DNA damage [7]. Different mutations in the XPD gene
can affect DNA repair and transcription differentially,
and this can explain the diverse clinical phenotypes
seen in patients. Analysis of the mutations in affected
individuals did indeed show that the site of each muta-
tion was specific for a particular clinical phenotype
[3,8]. This was conclusively demonstrated by the gen-
eration of the TTD mouse, which has the mutation
R722W, previously found in several TTD patients. 
The Hoeijmakers–Bootsma group, who generated
the mice, had previously postulated that most of the
features of TTD resulted from subtle deficiencies in
transcription caused by the mutation in XPD [9]. But
why would a general transcription deficiency result 
in the rather specific defects found in TTD humans
and the mice? They proposed that the XPD muta-
tions in TTD patients decreased the stability of the
TFIIH complex. Transcriptional deficiencies would only
become manifest in tissues at the end of their differ-
entiation pathway, like hair shafts, in which unstable
transcription complexes could not be replaced [5]. A
major unanswered question is why, despite the similar
repair deficiencies in XP and TTD individuals, TTD
patients show none of the sunlight-induced skin pig-
mentation changes or greatly elevated levels of skin
cancers found in XP.
Is the premature ageing in the TTD mice reported by
de Boer et al. [6] the consequence of deficiencies in
transcription, in DNA repair or in both? A decline in
DNA repair as a contributory cause of ageing was first
proposed many years ago, and several of the DNA
repair disorders — such as Cockayne Syndrome and
ataxia-telangiectasia — are associated with features
of premature ageing [10]. But null mutations in the
XPA gene totally abolish nucleotide excision repair,
yet neither XPA mice nor humans show signs of pre-
mature ageing [11,12]. So transcriptional deficiency
seemed a more likely candidate to account for the
ageing features of the TTD mice. When de Boer et al.
[6] crossed their TTD mice with XPA mice, however,
they found that the ageing features were greatly exac-
erbated in the double mutant mice. The only antici-
pated additional effect of the XPA mutation at the
molecular level is the reduction of nucleotide excision
repair from a low level in the TTD mice to complete
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Figure 1. A TTD mouse aged 15 months, showing aged appear-
ance, grey hair, cachexia and kyphosis. (Photo courtesy J.H.J.
Hoeijmakers.)
absence in the double mutant. The results with the
double mutant mice therefore show unequivocally that
DNA damage contributes to ageing of the TTD mice.
But as the XPA mice show no ageing features, it must
be the combination of repair defect together with the
transcription deficiency that causes the premature
ageing features.
CS has several features in common with TTD, namely
retarded growth, mental retardation, severe cachexia,
and sun sensitivity without increased cancer risk, but
in addition CS patients have skeletal abnormalities,
pigmented retinopathy and calcification of the basal
ganglia in the brain [13]. They do not have the brittle
hair phenotype, which is the hallmark of TTD. CS has
many features of premature ageing, although curi-
ously, for this disorder the manifestation of these fea-
tures in different organisms is the converse of TTD.
They are seen in the humans, but are not particularly
evident in a CS mouse model [14]. Most cases of CS
result from mutations in one of two genes, CSA and
CSB. These genes are required for transcription-
coupled repair of DNA damage. This is a specific
process that is responsible for the rapid removal of
damage from the transcribed strands of active genes.
Unlike XPD, which has an essential and clearly
defined role in transcription, the CS genes are not
essential for life in either man or mouse, so they do
not have a vital role in transcription. They do, however,
appear to have a subsidiary role, which is currently
thought to be in assisting RNA polymerase to over-
come structures which result in transcription stalling
[15]. As with the TTD mouse, it seems to be the com-
bination of repair and transcriptional deficiencies that
causes the premature ageing. The Hoeijmakers group
has previously reported that, as with the TTD mice,
when CS and XPA mice are crossed, the resulting
phenotype is much more severe [16].
The important findings in the recent Science paper
[6] raise many questions. At the molecular level, what
are the lesions in DNA that ultimately cause the pre-
mature ageing? De Boer et al. [6] suggest that oxida-
tive damage in DNA might be a strong candidate.
Does the combination of unrepaired damage and
transcriptional defect simply increase the rate of
apoptosis, thereby accelerating the ageing process, or
are there more complex mechanisms involved? Why
are the features of TTD and CS both qualitatively and
quantitatively different? The interaction of unrepaired
damage and transcriptional deficiency results in pre-
mature ageing in mutant mice and humans, but are
these same processes a major cause of ageing in
unaffected ‘normal’ individuals? The TTD mouse opens
up many new avenues for exploration.
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